186 related articles for article (PubMed ID: 24461891)
21. [Pulmonary arterial hypertension--a rare form of pulmonary hypertension].
Schenk M
Dtsch Med Wochenschr; 2010 May; 135(21):p21. PubMed ID: 20509110
[No Abstract] [Full Text] [Related]
22. Endothelin receptor blockade in congestive heart failure.
Cheng TO
Circulation; 2001 Oct; 104(18):E96. PubMed ID: 11684644
[No Abstract] [Full Text] [Related]
23. [Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomized placebo-controlled study].
Castro G
Rev Port Cardiol; 2001 Nov; 20(11):1151-2. PubMed ID: 11826707
[No Abstract] [Full Text] [Related]
24. Is distal chronic thromboembolic pulmonary hypertension treatable with PAH targeted drugs?
Cannon JE; Pepke-Zaba J
Semin Respir Crit Care Med; 2013 Oct; 34(5):620-6. PubMed ID: 24037629
[TBL] [Abstract][Full Text] [Related]
25. Effects of oral treatments on clinical outcomes in pulmonary arterial hypertension: A systematic review and meta-analysis.
Zhang HD; Zhang R; Jiang X; Sun K; Wu DC; Jing ZC
Am Heart J; 2015 Jul; 170(1):96-103, 103.e1-14. PubMed ID: 26093869
[TBL] [Abstract][Full Text] [Related]
26. Recruitment of pulmonary hypertension patients for PATENT trial with Riociguat [corrected] completed Sub-Saharan pulmonary hypertension study launched.
Aalbers J
Cardiovasc J Afr; 2012 Mar; 23(2):120. PubMed ID: 22447482
[No Abstract] [Full Text] [Related]
27. New insights into pulmonary hypertension.
Furlow B
Lancet Respir Med; 2013 Sep; 1(7):508. PubMed ID: 24461605
[No Abstract] [Full Text] [Related]
28. Bosentan for chronic thromboembolic pulmonary hypertension.
Confalonieri M; Kodric M; Longo C; Vassallo FG
Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1503-12. PubMed ID: 19954311
[TBL] [Abstract][Full Text] [Related]
29. [The current pharmacotherapy of pulmonary arterial hypertension].
Betkier-Lipińska K; Ryczek R; Cwetsch A
Pol Merkur Lekarski; 2015 Jan; 38(223):34-8. PubMed ID: 25763586
[TBL] [Abstract][Full Text] [Related]
30. [Updated treatment of primary pulmonary hypertension -- the role of endothelin receptor antagonists].
Callejas Rubio JL; Ortego Centeno N; Navarro Pelayo F; Vallejo Rodríguez I
Farm Hosp; 2004; 28(4):294-5. PubMed ID: 15369441
[No Abstract] [Full Text] [Related]
31. Macitentan (Opsumit) for pulmonary arterial hypertension.
Med Lett Drugs Ther; 2014 Feb; 56(1436):15-6. PubMed ID: 24663031
[No Abstract] [Full Text] [Related]
32. Recovery from mitomycin-induced pulmonary arterial hypertension.
Botros L; Van Nieuw Amerongen GP; Vonk Noordegraaf A; Bogaard HJ
Ann Am Thorac Soc; 2014 Mar; 11(3):468-70. PubMed ID: 24673706
[No Abstract] [Full Text] [Related]
33. The First Experience of Pulmonary Veno-occlusive Disease Treatment With Macitentan and Sildenafil.
Chamorro Fernández CI; Garcés Cabello P; Pérez Mateos R; Sánchez Soriano RM; Ferrando Siscar C; Quezada Loaiza CA
Rev Esp Cardiol (Engl Ed); 2017 May; 70(5):396-397. PubMed ID: 27840150
[No Abstract] [Full Text] [Related]
34. [Endothelin receptor antagonist bosentan. Breakthrough in the treatment of pulmonary hypertension].
MMW Fortschr Med; 2004 Dec; 146(50):72-3. PubMed ID: 15666438
[No Abstract] [Full Text] [Related]
35. Treatments for pulmonary arterial hypertension.
Liu C; Liu K; Ji Z; Liu G
Respir Med; 2006 May; 100(5):765-74. PubMed ID: 16549344
[TBL] [Abstract][Full Text] [Related]
36. Novel medical therapies for pulmonary arterial hypertension.
O'Connell C; O'Callaghan DS; Humbert M
Clin Chest Med; 2013 Dec; 34(4):867-80. PubMed ID: 24267310
[TBL] [Abstract][Full Text] [Related]
37. [Pharmacological and clinical profile of a novel dual endothelin receptor antagonist, macitentan (Opsumit
Takahashi S; Horie R; Yokoyama Y
Nihon Yakurigaku Zasshi; 2017; 149(1):49-58. PubMed ID: 28049880
[No Abstract] [Full Text] [Related]
38. Endothelin-receptor antagonists in pulmonary hypertension.
Dupuis J
Lancet; 2001 Oct; 358(9288):1113-4. PubMed ID: 11597660
[No Abstract] [Full Text] [Related]
39. Bosentan in inoperable chronic thromboembolic pulmonary hypertension.
Hughes R; George P; Parameshwar J; Cafferty F; Dunning J; Morrell NW; Pepke-Zaba J
Thorax; 2005 Aug; 60(8):707. PubMed ID: 16061720
[No Abstract] [Full Text] [Related]
40. [Opsumit for pulmonary hypertension].
Sabourin G
Perspect Infirm; 2014; 11(4):56. PubMed ID: 25269244
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
